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Abstract: The myocardium is mainly composed of long-lived postmitotic cells with, if there is any at all, a very low rate 
of replacement through the division and differentiation of stem cells. As a consequence, cardiac myocytes gradually un-
dergo pronounced age-related alterations which, furthermore, occur at a rate that inversely correlates with the longevity of 
species. Basically, these alterations represent the accumulation of structures that have been damaged by oxidation and that 
are useless and often harmful. These structures (so-called ‘waste’ materials), include defective mitochondria, aberrant cy-
tosolic proteins, often in aggregated form, and lipofuscin, which is an intralysosomal undegradable polymeric substance. 
The accumulation of ‘waste’ reflects the insufficient capacity for autophagy of the lysosomal compartment, as well as the 
less than perfect functioning of proteasomes, calpains and other cellular digestive systems. Senescent mitochondria are 
usually enlarged, show reduced potential over their inner membrane, are deficient in ATP production, and often produce 
increased amounts of reactive oxygen species. The turnover of damaged cellular structures is hindered by an increased 
lipofuscin loading of the lysosomal compartment. This particularly restricts the autophagic turnover of enlarged, defective 
mitochondria, by diverting the flow of lysosomal hydrolases from autophagic vacuoles to lipofuscin-loaded lysosomes 
where the enzymes are lost, since lipofuscin is not degradable by lysosomal hydrolases. As a consequence, aged lipofus-
cin-rich cardiac myocytes become overloaded with damaged mitochondria, leading to increased oxidative stress, apoptotic 
cell death, and the gradual development of heart failure. Defective lysosomal function also underlies myocardial degen-
eration in various lysosomal storage diseases, while other forms of cardiomyopathies develop due to mitochondrial DNA 
mutations, resulting in an accumulation of abnormal mitochondria that are not properly eliminated by autophagy. The deg-
radation of iron-saturated ferritin in lysosomes mediates myocardial injury in hemochromatosis, an acquired or hereditary 
disease associated with iron overload. Lysosomes then become sensitized to oxidative stress by the overload of low mass, 
redox-active iron that accumulates when iron-saturated ferritin is degraded following autophagy. Lysosomal destabiliza-
tion is of importance in the induction and/or execution of programmed cell death (either classical apoptotic or autophagic), 
which is a common manifestation of myocardial aging and a variety of cardiac pathologies. 
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INTRODUCTION  
  The cardiac muscle is a nonstop working machine that is 
characterized by a predominantly aerobic metabolism and 
one of the highest oxygen consumption rates of any organs 
[1]. Heart myocytes have long been considered irreplaceable, 
being as old as the whole organism. Only relatively recently, 
when stem cells with the potential to differentiate into ma-
ture myocytes were found even in adult hearts [2], was this 
view reconsidered. Yet, cardiac myocytes, along with neu-
rons and retinal pigment epithelial cells, are replaced much 
more slowly than most other tissues and, therefore, are called 
‘long-lived postmitotic cells’ [3]. It has been speculated that 
infrequent cell replacement might be advantageous for cer-
tain functions, such as long-term memory in neurons and 
compensatory hypertrophy in heart myocytes [4]. At any 
rate, both the intensive function and the low pace of re-
placement make cardiac myocytes highly vulnerable to dam-
age associated with aging and various diseases [5, 6].  
  Due to a basic, unavoidable electron leak from the mito-
chondrial electron transport chain and an imperfect antioxi- 
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dant defense system (primarily operated by superoxide dis-
mutase, catalase and glutathione peroxidase), normal bio-
logical respiration is associated with continuous mild oxida-
tive damage to biomolecules such as nucleic acids, proteins 
and lipids [7, 8]. This normal damage is not completely re-
paired and so has a tendency to accumulate over time. Ap-
parently, it is the main contributor to the progressive struc-
tural deterioration, reduced function, decreased adaptability, 
and increased probability of disease and death, i.e., biologi-
cal aging, or senescence [9, 10]. In a highly aerobic organ 
such as the heart, the manifestations of aging are extremely 
pronounced, involving first and foremost the mitochondria 
and the lysosomes of cardiac myocytes (see below).  
  Many lines of evidence suggest that a continuous en-
dogenous production of reactive oxygen species (ROS), es-
pecially from the mitochondria, is a major contributor to 
aging [7, 11]. In contrast to senescence, diseases affect par-
ticular individuals and are usually more dependent on condi-
tions. They often occur when the effects of damaging 
(pathogenic) factors exceed the organism’s adaptability. Due 
to the almost complete lack of repair of the heart muscle 
through proliferation, both myocardial aging and pathologies 
(such as ischemic heart disease, metabolic and inflammatory 
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For the same reason, tumors rarely develop in the myocar-
dium, in contrast to tissues with high proliferative capacity, 
such as the epithelium of the digestive tract and the bone 
marrow. Cells of the latter tissues show negligible senes-
cence, but a high incidence of neoplasms, deriving from un-
differentiated progenitor cells [12].  
  Lack of repair through proliferation increases the de-
mands on intracellular renewal mechanisms, which include 
not only the synthesis of macromolecules and organelle bio-
genesis, but also involves the systems responsible for re-
moval of damaged and obsolete cellular structures. These 
systems involve cytosolic proteases, proteasomes and, most 
importantly, lysosomes, which are responsible for the degra-
dation of virtually all types of intracellular material and a 
number of signaling pathways, including the regulation of 
apoptosis. Here we discuss the role of lysosomes in relation 
to myocardial aging and pathology.  
LYSOSOMES AND CARDIAC MYOCYTE HOMEO-
STASIS  
  The degradation within lysosomes of each cell’s own 
constituents is called autophagy, or autophagocytosis [13-
15]. Autophagy is an ongoing process, reflecting the need of 
cells for continuous (basic) renewal. Consequently, it needs 
to be emphasized that autophagy is a perfectly normal proc-
ess that is necessary for the normal turnover of organelles 
and a variety of biomolecules, mostly long-lived proteins. 
The regulation of, and the different steps involved in auto-
phagy have recently been explored in some detail, mainly 
through studies on yeast. Dozens of strikingly well con-
served autophagy-related proteins and corresponding genes 
have been discovered and given the name ‘Atg’ [16, 17]. 
These proteins have been found in various mammalian tis-
sues, including the myocardium [18] The importance of 
autophagy for normal heart function is demonstrated by the 
fact that cardiac-specific inhibition of Atg5 results in severe 
cardiomyopathy in mice [19]. 
  Autophagy, however, may also act as a life-sustaining 
mechanism under stress conditions by allowing cells to con-
tinue vital metabolism by ‘self-eating’ such parts that can be 
replaced later - in the event the cell survives. This type of 
autophagy is obviously an attempt of the cell to provide itself 
with substrates for ATP production and building blocks for 
essential anabolism by lysosomal degradation of various 
macromolecular structures [20]. Under starvation, cells in 
culture are thus found to considerably increase the rate of 
autophagy [21]. Prevention of autophagy (e.g. by inhibiting 
the formation of the autophagic membrane by 3-methyl-
adenine) or suppressing lysosomal enzyme activity, results in 
rapid cell death [21, 22]. In starving animals, autophagy is 
enhanced in the liver and the same is found in the hearts of 
newborn rats if feeding is withheld [23-25].  
  Autophagy is also activated in response to various stres-
sors associated with abnormal damage to cellular structures, 
e.g. oxidants, ionizing radiation, hypoxia, etc. This type of 
autophagy may be named reparative autophagy, since its 
purpose is to rid the cell of damaged structures and replace 
them with new ones. In cardiac myocytes, reparative auto-
phagy most commonly occurs under ischemia/reperfusion 
[26-29] as well as under in vitro conditions that imitate such 
type of stress [30]. Insufficient reparative autophagy may 
lead to irreversible cell injury when damaged, poorly per-
forming mitochondria accumulate and start to release ROS 
and pro-apoptotic molecules, culminating in programmed 
cell death, PCD (see below).  
  Depending on how material destined for degradation en-
ters lysosomes, three types of autophagy are recognized in 
mammalian cells: macroautophagy, microautophagy, and 
chaperone-mediated autophagy (Fig. (1)). In macroauto-
phagy, a portion of cytoplasm is enclosed in a double-
membrane-bound vacuole termed the autophagosome [13-
15]. Precursors of autophagosomes are called phagophores 
[31] or pre-autophagosomes [32]. They emerge as small 
vesicles that transform into cup-like structures and then into 
double-membrane vacuoles (autophagosomes) when the 
edges of the ‘cups’ fuse. The origin of the autophagosome 
membrane is still disputed. It was assumed that it might arise 
from other organelles such as the endoplasmic reticulum or 
the Golgi complex [31]. Studies on yeast, however, sug-
gested the de novo development of such a membrane because 
it showed a unique protein composition, different from that 
in other biological membranes [33]. Autophagosomes then 
fuse with lysosomes or late endosomes, and the engulfed 
material is degraded by a variety of hydrolytic enzymes. 
Macroautophagy is the most universal form of autophagy, 
providing for degradation of almost all types of cellular 
structures including proteins, lipids, complex carbohydrates, 
nucleic acids and other biomolecules, as well as various or-
ganelles, such as mitochondria, fragments of endoplasmic 
reticulum, ribosomes, and peroxisomes [3, 15]. Macroauto-
phagy is particularly important for cardiac myocytes whose 
abundant, actively respiring, mitochondria suffer oxidative 
damage and need to be efficiently turned over.  
  In microautophagy, macromolecules or small organelles 
are taken up by lysosomes through invagination of the 
lysosomal membrane, initially resulting in the formation of 
multivesicular bodies [14]. Microautophagy has been de-
scribed in various cell types including cardiac myocytes [20].  
  Chaperone-mediated autophagy (CMA) is the selective 
transport of specific proteins into lysosomes by molecular 
chaperones. Targeted proteins contain an amino acid se-
quence KFERQ (lysine-phenylalanine-glutamate-arginine-
glutamine) that is recognized by a heat-shock chaperone pro-
tein Hsp73. The substrate-chaperone complex then binds to 
the lysosome-associated membrane protein 2a (LAMP-2a) 
and enters the lysosome [34-36].  
LYSOSOMES AND CELL DEATH  
  While autophagy is a programmed degradation of altered 
cellular constituents, PCD is a removal of irreversibly dam-
aged cells. Autophagy usually promotes cell survival, but 
when cellular damage is pronounced, it can also participate 
in PCD (see below). Both autophagy and PCD are adaptive 
processes, working in concert and providing for renewal of 
the organism’s constituents and life maintenance. PCD, un-
like necrosis (accidental cell death), is a form of cell death 
that involves minimal damage to adjacent cells. It occurs 
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constituents are degraded by a family of cytosolic cysteine 
endopeptidases called caspases, or through autophagic cell 
death (PCD-II) in which cell parts are autophagocytosed and 
digested within lysosomes [37, 38]. Often classic, caspase-
mediated apoptosis and autophagic cell death are mixed, 
with dying cells showing both caspase activation and en-
hanced numbers of autophagosomes [37, 38].  
  PCD plays a major role in the elimination of unneces-
sary, damaged, or diseased cells during the whole life span, 
and is especially prominent during embryogenesis, when a 
majority of newly formed cells undergo PCD during the de-
velopment of the individual. Major pathologies, such as can-
cer and neurodegenerative diseases, are associated with an 
abnormal depression or enhancement, respectively, of PCD, 
and apoptotic cell death with a secondary dystrophic calcifi-
cation seems to be an important factor in the formation of 
atherosclerotic plaques [39, 40].  
  Although Christian de Duve, who discovered lysosomes 
in the late 1950s, nicknamed them ‘suicide bags’, lysosomes 
for a long time were believed to be of importance only for 
necrotic (accidental) cell death, while true cell suicide, 
named apoptosis (currently known as PCD-I, see above), 
was considered an effect of either ligation of death receptors 
along the plasma membrane (the external pathway) that sets 
off a cascade of caspase activation, or the release of pro-
apoptotic mitochondrial proteins due to apoptogenic stimuli 
from within the cell (the internal pathway) [41, 42]. It needs 
to be pointed out that the external pathway usually also af-
fects mitochondria resulting in the release of apoptogenic 
agonists. Both of these pathways involve the activation of a 
cascade of caspases and result in a controlled manner of cell 
death by which the affected cells are fragmented into apop-
totic bodies with an intact surrounding plasma membrane. 
The apoptotic bodies are then phagocytosed by neighboring 
cells, or by professional scavengers such as macrophages, 
resulting in a quiet and peaceful elimination of the apoptotic 
cells without the inflammatory response that is seen in ne-
crosis [43]. Moreover, the apoptotic cells are not wasted but 
serve as ‘food’ following degradation within the lysosomal 
compartment of the engulfing cells.  
  Several years ago, the finding of lysosomal membrane 
labilization prior to manifested PCD, especially in oxidative 
stress-induced apoptosis, in combination with the observa-
tion that lysosomotropic detergents, which specifically dam-
age lysosomes, induce classical apoptosis, led to the sugges-
tion that lysosomes were involved in the apoptotic process 
(reviewed in [44, 45]). However, this idea initially evoked 
limited enthusiasm among the more doctrinaire cell death 
experts. Not until it was shown that activation of the pro-
apoptotic proteins, Bid and Bax, could be accomplished by 
lysosomal proteases, did the role of lysosomes in apoptosis 
become somewhat more widely recognized [46, 47]. 
  Moderate oxidative stress is known to induce classical 
apoptosis of most cells in culture, but higher levels of such 
stress are more closely associated with necrosis [44, 48-50]. 
An upstream event in the apoptotic process induced by oxi-
Fig. (1). Autophagy in mammalian cells. Intracellular material enters lysosomes for degradation through macroautophagy, microautophagy 
or chaperone-mediated autophagy. Mature lysosomes evolve from late endosomes as a result of their increasing acidification and enrichment 
with lysosomal enzymes (LE). The latter are delivered (in mannose-6-phosphate receptor-bound form) within specific transport vesicles that 
are pinched off from the trans-Golgi network. Oxidized, polymerized and undegradable material accumulates within lysosomes in the form 
of lipofuscin. Lipofuscin-loaded lysosomes maintain an acidic pH and experience permanent influx of lysosomal enzymes. Thin black arrows 
indicate evolution of structures, thick gray arrows symbolize fusion, while arrowheads show transport processes. References are given in the 
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dative stress was found to be lysosomal rupture due to iron-
catalyzed peroxidation of lysosomal membranes that, in turn, 
was a consequence of the high concentrations of low-mass 
iron compounds in many lysosomes secondary to autophagic 
degradation of ferruginous materials, such as mitochondrial 
respiratory complexes [51-54]. Lysosomal rupture and con-
sequent apoptosis or necrosis following oxidative stress was 
shown to be a function of the concentration of low-mass iron 
compounds within lysosomes. Similarly the varied degrees 
of stability of lysosomes in a single cell are probably a re-
flection of whether or not the individual lysosome has re-
cently been engaged in autophagy of ferruginous structures 
[15, 55-57]. It follows that in iron-overload diseases, such as 
in the various forms of hemochromatosis, when lysosomes 
are known to be rich in low-mass compounds containing 
labile iron, the lysosomes, and thereby their host cell as well, 
are abnormally sensitive to oxidative stress [56, 58-60].  
  Given the importance of keeping the labile redox-active 
iron content of lysosomes as low as possible in order to 
minimize the occurrence of rupture and ensuing apopto-
sis/necrosis, it might be expected that mechanisms to this 
end have evolved. It seems they have: it has been found that 
cells with upregulated phase II stress proteins, such as fer-
ritin, metallothioneins and heat shock proteins are particu-
larly resistant to oxidative stress [61-64]. It appears that one 
of the molecular mechanisms behind this resistance is a con-
tinuous autophagic turnover of these proteins that for a lim-
ited period of time are able to bind iron within lysosomes in 
non-redox-active form.  
  It may be speculated that excessive levels of autophagy 
associated with cell repair or starvation (see above) result in 
rupture of some autophagolysosomes with release of lyso-
somal hydrolases and ensuing apoptosis. The mechanism 
behind such rupture may be that the lysosomal compartment 
is greatly enriched with labile iron when substantial parts of 
it have been subjected to autophagy, e.g., as a result of deg-
radation of mitochondria containing metalloproteins such as 
cytochrome c (Fig. (2)). It can be assumed that even a nor-
mal, or only slightly elevated, ROS production would be 
enough to rupture iron-rich lysosomes [65].  
  As mentioned above, classical apoptosis (PCD-1) is often 
mixed with autophagic cell death (PCD-2). Lysosomes are 
involved in both cases, although in PCD-1 lysosomal en-
zymes mainly participate in the initiation of apoptosis, while 
in PCD-2 they are the instruments of cell death. The relation-
ship between PCD-1 and PCD-2 follows, in particular, from 
the fact that Bcl-2 not only inhibits classical apoptosis but 
also autophagy through suppression of Beclin1 [66]. Con-
versely, suppression of Bcl-2 would activate both PCD-1 and 
PCD-2 [18]. Beclin1-mediated autophagy seems to be in-
volved in myocardial degeneration in ischemia/reperfusion 
injury, while reparative autophagy in mild ischemia is stimu-
lated by an AMP-activated protein kinase [29]. Autophagic 
degeneration and death of cardiac myocytes has been shown 
to be a common event in the failing heart [67-70]. 
IMPERFECT LYSOSOME FUNCTION IN AGING 
AND HEART DISEASE  
  One of the most obvious subcellular characteristics of 
aging postmitotic cells is a time-dependent accumulation of 
the age pigment lipofuscin within the lysosomal compart-
ment [71]. This accumulation is inversely related to the life 
span and, consequently, similar postmitotic cells, including 
cardiac myocytes, become loaded at very different rates 
when short-lived animals are compared to long-lived ones 
[72]. This fact by itself suggests that the accumulation of 
lipofuscin is a disadvantage for cells and may hamper impor-
tant functions. Lipofuscin is a yellow-brownish pigment with 
a broad autofluorescence in response to excitation with ul-
traviolet, blue or green light [73]. It is a heterogeneous poly-
mer composed of protein fragments linked together by alde-
hyde bridges, which arises from decomposed lipid-derived 
peroxides. The formation of lipofuscin demands iron-
catalyzed peroxidation of intralysosomal material under de-
composition, and autophagocytosed mitochondria seem to be 
a major source of lipofuscin [74, 75].  
Fig. (2). Tentative mechanism of lysosomal membrane permeabilization secondary to enhanced reparative autophagy. Reparative 
autophagy is induced by cellular damage under stress conditions. It is associated with increased number and size of lysosomes 
(autolysosomes) containing mitochondria and other damaged cellular structures under degradation. This may result in the release of redox-
active iron from mitochondrial metalloproteins, activation of Fenton reactions and generation of hydroxyl radicals with ensuing damage to 
the lysosomal membrane (shown as dashed line). See detailed explanations in the text. The Involvement of Lysosomes in Myocardial Aging and Disease  Current Cardiology Reviews, 2008, Vol. 4, No. 2    111
  In cell culture systems, the formation of lipofuscin (or 
ceroid as the material is often called when accumulated due 
to processes other than pure aging) can easily be influenced. 
The addition of purified mitochondria to human astrocyte 
cultures was found to induce the phagocytosis of these or-
ganelles with ensuing transport to the lysosomal compart-
ment and their rapid conversion to lipofuscin-like material, 
verifying that mitochondria may be an origin of lipofuscin 
[76]. When neonatal rat cardiac myocytes, or growth-
arrested human foreskin fibroblasts, are cultured at 40% am-
bient oxygen, or in the presence of enhanced amounts of iron 
in the medium, lipofuscin formation is much accelerated in 
comparison to standard culture conditions. On the other 
hand, culture at 8% ambient oxygen dramatically reduces 
lipofuscin formation as compared to standard conditions [77, 
78]. These findings point to the importance of iron-catalyzed 
intralysosomal oxidation for the formation of lipofuscin and 
suggest that enhanced or delayed intralysosomal degradation 
would decrease or increase, respectively, the rate of pigment 
formation, given the same degree of oxidative stress. Rapid 
degradation of the precursor material should limit the time 
available for its oxidation and conversion to lipofuscin, while 
slow degradation gives more time for the oxidative creation 
of lipofuscin. The application of inhibitors of lysosomal en-
zymes has verified this hypothesis by showing that, indeed, 
the prolongation of intralysosomal degradation substantially 
increases the formation of lipofuscin per unit time [77].  
  Lipofuscin amasses within aging cardiac myocytes and 
other long-lived postmitotic cells because it is neither de-
graded, nor exocytosed to any considerable degree. This fol-
lows, in particular, from the facts that cultured neonatal rat 
cardiac myocytes and growth-inhibited human fibroblasts 
did not show any reversal of lipofuscin content after removal 
of factors that initially induced its accumulation, i.e., oxida-
tive stress and protease inhibition [77, 78]. Moreover, lipo-
fuscin was not degraded even when fibroblasts were exposed 
to amino acid starvation, associated with enhanced intra-
lysosomal degradation [21]. 
  Along with lipofuscin accumulation, reflecting incom-
plete degradation of autophagocytosed material, myocardial 
aging is characterized by the accretion of extralysosomal 
‘waste’ material, including first of all defective mitochondria 
that for some reason escape autophagic sequestration. It may 
be speculated that these mitochondria are poorly recognized 
for autophagy, but this assumption lacks any credible ex-
perimental support. De Grey suggested that mitochondria 
harboring DNA mutations (due to oxidation or replicative 
errors) and, therefore, poorly respiring and producing de-
creased amounts of ROS, experience only slight oxidative 
damage to their membranes. This might make them less 
likely to be targeted for autophagy as compared to normal 
mitochondria and results in their progressive accumulation 
[79]. Yet, this is still a hypothesis. Our study on neonatal rat 
cardiac myocytes suggests that enlarged mitochondria 
(which may appear due to disturbed mitochondrial fission 
secondary to oxidative damage) are autophagocytosed less 
efficiently than mitochondria of small sizes, leading to their 
progressive accumulation with age [80]. This observation 
may explain the accumulation of so-called ‘giant’ mitochon-
dria in aged cardiac myocytes [81] (Fig. (3)).  
  There are good reasons to believe that in aged cardiac 
myocytes and other postmitotic cells, extralysosomal ‘gar-
bage’ accumulation is to a large extent secondary to lipofus-
cin accumulation. Intralysosomal degradation requires a va-
riety of hydrolytic enzymes that are matured in the trans-
Golgi network and then transported away in tiny, coated 
vesicles to fuse with late endosomes, which then develop 
into lysosomes.  
  Cytochemical studies on lipofuscin-loaded lysosomes 
have shown that such lysosomes contain not only lipofuscin, 
but also lysosomal enzymes, indicating that they receive 
Fig. (3). Tentative mechanism of selective accumulation of giant mitochondria. Normal turnover of mitochondria is associated with their 
continuous removal by autophagy and fusion/fission, generating new mitochondria and preventing mitochondrial enlargement (a). Mito-
chondrial damage (e.g., by ROS) may lead to disturbed fission and enlargement of certain mitochondria (b). There is a reason to believe that 
autophagy of enlarged mitochondria is energy consuming and thus more complicated than that of normal mitochondria. Because of this, a 
further mitochondrial enlargement and a progressive amassing of giant dysfunctional mitochondria may take place within long-lived postmi-
totic cells, such as cardiac myocytes. 112 Current Cardiology Reviews, 2008, Vol. 4, No. 2 Terman et al. 
their share of newly produced lysosomal enzymes [82]. Con-
sidering the large number of lipofuscin-loaded lysosomes in 
aged postmitotic cells, it is reasonable to assume that a ma-
jority of the newly produced lysosomal enzymes end up in 
lysosomes that are completely filled with lipofuscin. Because 
lipofuscin is non-degradable, such enzymes would be lost to 
any meaningful activity [83]. Given that there should be an 
upper limit to the possible production of lysosomal enzymes, 
such a dysfunctional allocation of lysosomal enzymes would 
finally cause a situation when lysosomal digestion would be 
hampered by lack of degradation capacity. Resulting from a 
predominant transport of newly produced lysosomal hydro-
lases to lipofuscin-loaded lysosomes, being a consequence of 
their large number, lysosomes which have not yet accumu-
lated lipofuscin, would lack sufficient enzymes for optimal 
digestion. The result would be the accumulation of old and 
damaged mitochondria and other cellular ‘waste’ products, 
such as misfolded proteins and various materials clumped 
together in aggresomes [84]. Indeed, when autophagy is 
hampered in experiments, it has been found to result in the 
intracellular accumulation of various waste products [85], 
while lipofuscin-rich myocardial cells that were aged in vitro
have been found to show signs of disturbed autophagy and 
the presence of aged, dysfunctional mitochondria [86]. 
  In support of these ideas are the findings that autophagy 
is indeed depressed in aged cells [87-89]. The consequence 
is an accumulation of old and damaged mitochondria with 
reduced membrane potential and ATP production, but with 
increased production of superoxide and hydrogen peroxide 
[90, 91]. Such increased oxidative stress in turn may initiate 
a cross-talk between mitochondria and the lysosomal com-
partment where lysosomes are induced to leak lytic enzymes 
that in turn may further damage mitochondria. Such interplay 
between lysosomes and mitochondria may finally induce 
apoptosis due to release of lysosomal hydrolases and trunca-
tion of Bid/Bax (see above). This scenario is the basis for our 
mitochondrial-lysosomal axis theory of postmitotic aging 
and apoptosis [91].  
  The question regarding harmful effects of lipofuscin on 
cellular functions is still somewhat debated. In a recent pa-
per, fibroblasts with elevated quantities of lipofuscin due to 
prolonged cultivation of cells in 40% ambient oxygen have 
been found increasingly resistant to complete starvation (ex-
posure to phosphate-buffered saline) [92]. It should be 
pointed out that cultivation of cells in 40% oxygen (mild 
oxidative stress) makes them more resistant to oxidative 
damage that occurs during starvation. Cells with low lipofus-
cin content (used as controls) were not exposed to 40% oxy-
gen and, therefore, a higher resistance of lipofuscin-rich cells 
to starvation could rather depend on preconditioning to oxi-
dative stress than on lipofuscin per se [93]. Our earlier ob-
servations, in which fibroblasts from same culture dishes but 
with different lipofuscin content were compared, demon-
strated decreased resistance of lipofuscin-rich cells to amino 
acid starvation [21] or acute oxidative stress [94].  
  Progressive damage to mitochondria and lysosomes de-
creases the adaptability of cardiac myocytes and enhances 
their sensitivity to injury, which is consistent with a growing 
incidence of cardiomyopathies and heart failure with advanc-
ing age [95, 96]. Heart insufficiency develops much faster if 
lysosomes or mitochondria are already affected, for example 
as a result of lysosomal storage diseases or mitochon-
driopathies. Lysosomal storage diseases, such as the Fabry, 
Pompe, or Danon diseases, are associated with hereditary 
defects in genes coding for lysosomal enzymes or other pro-
teins involved in lysosomal degradation, resulting in de-
creased autophagic turnover and a dramatic accumulation of 
intralysosomal ‘waste’ material [97-99]. In agreement with 
the scenario suggested in the mitochondrial-lysosomal axis 
theory, postmitotic cells affected by lysosomal storage dis-
eases have been shown to contain increased amounts of de-
fective, quasi-senescent, giant mitochondria [100, 101]. In 
mitochondrial cardiomyopathies, which are associated with 
mutations in mitochondrial DNA, cardiac myocytes accumu-
late large numbers of dysfunctional, usually enlarged mito-
chondria [102]. We speculate that these changes may be as-
sociated with insufficient mitochondrial autophagy, as de-
scribed above (Fig. (3)), although this possibility has never 
been investigated.  
  In late hemochromatosis, when myocardial cells are 
overwhelmed by accumulating iron and most ferritin is al-
most fully iron-saturated, autophagy exacerbates the situa-
tion rather than mitigates it, as autophagy of completely iron-
saturated ferritin releases, rather than binds lysosomal redox-
active iron. This might explain the often sudden onset of 
cardiac and liver failure in progressive hemochromatosis 
when probably most ferritin is iron-saturated. In support of 
this hypothesis, we recently found that endocytotic uptake of 
fullyiron-saturatedferritin considerably sensitized lysosomes 
to oxidative stress, while endocytosis of apo-ferritin and non 
iron-saturated ferritin had the opposite effect (Kurz et al. in 
preparation). 
  It is well known that aged hearts are more sensitive to 
oxidativestress, e.g. during ischemia/reperfusion, than young 
ones [103]. Previously, we showed that lipofuscin-loaded 
cells in culture were sensitized to oxidative stress, something 
that was considered an effect of the high iron-content of lipo-
fuscin [94]. In support of this idea, it has recently been 
shown that the higher sensitivity to ischemia/reperfusion of 
old hearts compared to young ones can be substantially ame-
liorated by perfusion with iron-chelators [103]. Reperfusion 
of ischemic organs causes substantial oxidative stress with 
resulting lysosomal damage due to intralysosomal peroxida-
tive processes, followed by destabilization of the lysosomal 
membranes. This can be effectively counteracted by water or 
lipid-soluble iron-chelators that penetrate into lysosomes and 
bind their content of low-mass-iron compounds into a non-
redox active form [104, 105]. Since it seems that oxidative 
stress, such as ischemia/reperfusion, damages cells and tis-
sues mainly because of oxidative stress-induced lysosomal 
injury, with resulting apoptosis/necrosis, we suggest that 
low-molecular-weight iron chelators, such as salicylaldehyde 
isonicotinoyl hydrazone (SIH) [105-107] or 1,2-dimethyl-3-
hydroxypyridin-4-one (deferiprone, L1, CP20) [108, 109] 
that easily penetrate cellular membranes should be added to 
preservation solutions. Then, hopefully, heart, liver, kidney, 
etc. transplants might survive longer in vitro and have im-
proved viability after transplantation. Furthermore, similar 
chelators could be formulated into therapeutic intravenous 
solutions for emergency treatment of myocardial infarction, The Involvement of Lysosomes in Myocardial Aging and Disease  Current Cardiology Reviews, 2008, Vol. 4, No. 2    113
brain ischemia, and brain hemorrhage. Moreover, repeated 
iron chelation could prevent or slow down formation of un-
degradable material intralysosomally and might therefore 
serve as an aging intervention strategy. 
CONCLUSION 
  Taken together, there seems to be substantial evidence to 
support the hypothesis that the high accumulation of lipofus-
cin found in myocardial and other postmitotic cells at the 
very end of all animals’ lifespans hampers normal autophagy 
and results in the intracellular concentration of aged and mal-
functioning mitochondria, misfolded proteins, and other 
waste products that together appear to have a destructive 
effect on the performance and survival of such cells. The 
high concentration of low-mass-iron that seems to be loosely 
bound to lipofuscin also induces an increased sensitivity of 
lipofuscin-loaded lysosomes to oxidative stress. 
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